84 related articles for article (PubMed ID: 15158092)
1. Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia.
Verstovsek S; Giles FJ; O'Brien S; Faderl S; Kantarjian HM; Keating MJ; Albitar M
Leuk Res; 2004 Jul; 28(7):707-11. PubMed ID: 15158092
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia.
Verstovsek S; Manshouri T; Smith FO; Giles FJ; Cortes J; Estey E; Kantarjian H; Keating M; Jeha S; Albitar M
Cancer; 2003 May; 97(9):2212-7. PubMed ID: 12712473
[TBL] [Abstract][Full Text] [Related]
3. Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia.
Verstovsek S; Kantarjian H; Manshouri T; Cortes J; Faderl S; Giles FJ; Keating M; Albitar M
Cancer; 2003 Mar; 97(5):1248-52. PubMed ID: 12599232
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity in myelodysplastic syndromes.
Gürkan E; Tanriverdi K; Başlamişli F
Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
[TBL] [Abstract][Full Text] [Related]
7. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
Bechter OE; Eisterer W; Pall G; Hilbe W; Kühr T; Thaler J
Cancer Res; 1998 Nov; 58(21):4918-22. PubMed ID: 9810000
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in myelodysplastic syndrome.
Fu C; Chen Z
Chin Med J (Engl); 2002 Oct; 115(10):1475-8. PubMed ID: 12490090
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of telomerase activity in multiple myeloma.
Shiratsuchi M; Muta K; Abe Y; Motomura S; Taguchi F; Takatsuki H; Uike N; Umemura T; Nawata H; Nishimura J
Cancer; 2002 Apr; 94(8):2232-8. PubMed ID: 12001122
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia.
Ma W; Kantarjian H; O'Brien S; Jilani I; Zhang X; Estrov Z; Ferrajoli A; Keating M; Giles F; Albitar M
Cancer; 2008 Mar; 112(6):1306-12. PubMed ID: 18224667
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity and telomere length in acute leukemia: correlations with disease progression, subtypes and overall survival.
Wang Y; Fang M; Sun X; Sun J
Int J Lab Hematol; 2010 Apr; 32(2):230-8. PubMed ID: 19614710
[TBL] [Abstract][Full Text] [Related]
12. Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications.
Tadmor T; Shvidel L; Aviv A; Ruchlemer R; Bairey O; Yuklea M; Herishanu Y; Braester A; Rahimi-Levene N; Vernea F; Ben-Ezra J; Bejar J; Polliack A;
Cancer; 2013 May; 119(10):1853-9. PubMed ID: 23423815
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
Gentile M; Mauro FR; Calabrese E; De Propris MS; Giammartini E; Mancini F; Milani ML; Guarini A; Foà R
Br J Haematol; 2005 Aug; 130(4):549-57. PubMed ID: 16098069
[TBL] [Abstract][Full Text] [Related]
15. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
16. Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia.
Pratt G; Harding S; Holder R; Fegan C; Pepper C; Oscier D; Gardiner A; Bradwell AR; Mead G
Br J Haematol; 2009 Jan; 144(2):217-22. PubMed ID: 19016722
[TBL] [Abstract][Full Text] [Related]
17. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and clinical staging in chronic lymphocytic leukemia.
Rai KR; Han T
Hematol Oncol Clin North Am; 1990 Apr; 4(2):447-56. PubMed ID: 2182601
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
[TBL] [Abstract][Full Text] [Related]
20. Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.
Kokhaei P; Palma M; Hansson L; Osterborg A; Mellstedt H; Choudhury A
Exp Hematol; 2007 Feb; 35(2):297-304. PubMed ID: 17258078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
